Parametric Portfolio Associates’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.13M Buy
40,228
+5,464
+16% +$204K ﹤0.01% 2724
2021
Q4
$1.6M Buy
34,764
+9,398
+37% +$404K ﹤0.01% 2575
2021
Q3
$833K Sell
25,366
-3,543
-12% -$110K ﹤0.01% 2882
2021
Q2
$1.01M Buy
28,909
+9,924
+52% +$338K ﹤0.01% 2768
2021
Q1
$686K Buy
18,985
+1,064
+6% +$33.3K ﹤0.01% 3337
2020
Q4
$520K Sell
17,921
-17,684
-50% -$506K ﹤0.01% 3365
2020
Q3
$1M Buy
35,605
+3,474
+11% +$103K ﹤0.01% 2917
2020
Q2
$1.04M Buy
32,131
+14,657
+84% +$526K ﹤0.01% 2904
2020
Q1
$712K Sell
17,474
-8,605
-33% -$458K ﹤0.01% 2978
2019
Q4
$1.61M Sell
26,079
-4,185
-14% -$277K ﹤0.01% 2827
2019
Q3
$2.21M Sell
30,264
-1,793
-6% -$134K ﹤0.01% 2577
2019
Q2
$2.63M Buy
32,057
+6,802
+27% +$484K ﹤0.01% 2479
2019
Q1
$1.78M Buy
25,255
+2,070
+9% +$122K ﹤0.01% 2722
2018
Q4
$1.04M Buy
23,185
+2,541
+12% +$133K ﹤0.01% 2959
2018
Q3
$1.17M Sell
20,644
-992
-5% -$60.7K ﹤0.01% 3006
2018
Q2
$1.45M Buy
21,636
+1,948
+10% +$122K ﹤0.01% 2863
2018
Q1
$1.15M Buy
19,688
+4,328
+28% +$275K ﹤0.01% 2944
2017
Q4
$990K Sell
15,360
-408
-3% -$25.4K ﹤0.01% 3025
2017
Q3
$828K Buy
15,768
+798
+5% +$38.1K ﹤0.01% 3145
2017
Q2
$701K Buy
14,970
+3,133
+26% +$151K ﹤0.01% 3178
2017
Q1
$586K Sell
11,837
-829
-7% -$46.5K ﹤0.01% 3121
2016
Q4
$768K Buy
12,666
+1,010
+9% +$61.8K ﹤0.01% 2977
2016
Q3
$773K Buy
11,656
+3,240
+38% +$203K ﹤0.01% 2948
2016
Q2
$470K Buy
8,416
+291
+4% +$14.1K ﹤0.01% 3232
2016
Q1
$273K Buy
+8,125
New +$276K ﹤0.01% 3639
2015
Q3
Sell
-7,113
Closed -$441K 3266
2015
Q2
$441K Sell
7,113
-8,972
-56% -$534K ﹤0.01% 3351
2015
Q1
$1.01M Sell
16,085
-1,880
-10% -$114K ﹤0.01% 2782
2014
Q4
$1.01M Buy
17,965
+4,050
+29% +$179K ﹤0.01% 2776
2014
Q3
$394K Buy
13,915
+1,687
+14% +$50.6K ﹤0.01% 3343
2014
Q2
$421K Buy
12,228
+441
+4% +$13.8K ﹤0.01% 3310
2014
Q1
$370K Buy
+11,787
New +$313K ﹤0.01% 3341

Other funds holding ANIP